#ResearchNeverStops

EVT Execute

Our services

EVT Innovate

Our R&D initiatives

Career

What you can contribute

Invest

How you can participate

Highlights

Company presentation

July 2021

Download

Virtual Capital Markets Day 2021

Watch the recorded webcast

Webcast

DDup 10

Evotec’s transforming transcriptomics toxicology platform

News View all news

Evotec spin-off Topas Therapeutics extends Series B, raising total of € 40 m (~$ 48 m) in this round

Hamburg, Germany, 29 Jul 2021

Evotec spin-off company Topas Therapeutics GmbH ("Topas"), a private biotechnology company developing immune tolerance-inducing drugs to...

Read more

Evotec creates long-term growth opportunities by initiating “Campus Levi-Montalcini” in Verona

Hamburg, Germany, 01 Jul 2021

Evotec SE today announced that Evotec has added significant opportunities for further, long-term growth by acquiring the Verona site...

Read more

Investor Relations Events View all events

1 September2021

2 September2021

Stifel 2021 London Cross Sector Insight Conference Organisers: Stifel

11 August2021

Half-year 2021 Interim Report and webcast

Resources and Insights sciencepool.evotec.com

TOP